Inventor
Daniel Cohen
Inventor
Saint Cloud, FR
Overview
Patents· 74 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%
C07KPeptides9%
A01KAnimal husbandry4%
C12NMicroorganisms or enzymes3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C09DCoating compositions, e.g. paints, varnishes or lacquers2%
Y10TTechnical subjects covered by former us classification2%
A63CSkates1%
PatentTitleYear
10,940,147Early treatment of CMT disease202110,905,672Combination of baclofen, acamprosate and medium chain triglycerides for the treatment of neurological disorders202110,905,686Compositions for treating CMT and related disorders202110,874,644Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse function202010,849,851Stable oral solutions for combined API202010,799,499Combinatorial therapies of neurological disorders202010,736,876Idalopirdine-based combinatorial therapies of Alzheimer's disease202010,682,342Compositions for treating amyotrophic lateral sclerosis202010,617,689Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level202010,596,160Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level202010,583,135Compositions for treating CMT and related disorders202010,463,640Therapeutic approaches for treating CMT and related disorders201910,441,558Therapeutic approaches for treating CMT and related disorders201910,434,109Compositions for treating neurological disorders201910,406,251PD-L1 binding polypeptides for imaging201910,383,870Early treatment of CMT disease201910,377,806Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides and uses thereof201910,350,195Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse function201910,342,784Compositions for treating amyotrophic lateral sclerosis201910,342,768Therapeutic approaches for treating Parkinson's disease201910,322,101Therapeutic approaches for treating CMT and related disorders201910,300,015Stable oral solutions for combined API201910,265,304Nootropic compositions for improving memory performance201910,189,883Therapeutic uses of modified FGF-21 polypeptides201910,092,554Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level201810,045,971Compositions for treating amyotrophic lateral sclerosis201810,010,515Therapeutic approaches for treating Parkinson's disease201810,004,744Therapeutic approaches for treating Parkinson's disease20189,945,876Diagnostic tools for charcot-marie-tooth disease20189,931,326Composition comprising torasemide and baclofen for treating neurological disorders20189,867,837'Compositions for treating neurological disorders'20189,820,978'Treatment of cerebral ischemia'20179,789,098'Nootropic compositions for improving memory performance'20179,636,316'Baclofen and acamprosate based therapy of neurological disorders'20179,631,004'Modified FGF-21 polypeptides comprising an internal deletion and uses thereof'20179,597,297'Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders'20179,566,275'Compositions for treating CMT and related disorders'20179,545,389'Baclofen and acamprosate based therapy of macular degeneration disorders'20179,493,834'Method for detecting a panel of biomarkers'20169,494,605'Diagnostic tools for charcot-marie-tooth disease'20169,434,778'Modified FGF-21 polypeptides comprising an internal deletion and uses thereof'20169,427,436'Compositions for treating CMT and related disorders'20169,393,241'Compositions for treating CMT and related disorders'20169,387,206'Therapeutic approaches for treating Alzheimer\'s disease'20169,248,111'Therapeutic approaches for treating parkinson\'s disease'20169,241,933'Compositions for treating amyotrophic lateral sclerosis'20169,144,558'Baclofen and acamprosate based therapy of neurological disorders'20158,992,891'Therapeutic approaches for treating CMT and related disorders'20158,865,769'Baclofen and acamprosate based therapy of neurological disorders'20148,809,302'Therapeutic approaches for treating alzheimer\'S disease'20148,741,886'Baclofen and acamprosate based therapy of neurological disorders'20148,716,269'Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders'20148,642,566'Therapeutic approaches for treating neuroinflammatory conditions'20148,571,804'Disease treatment by predicting drug association'20138,552,041'Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response'20138,383,565'Color changing paint and varnish remover'20138,198,226'Color changing paint and varnish remover'20127,371,811'Schizophrenia associated genes, proteins and biallelic markers'20087,304,021'Color changing paint and varnish remover'20077,189,833'Prostate cancer gene'20077,105,353'Methods of identifying individuals for inclusion in drug studies'20067,105,808'Plasma ion mobility spectrometer'20067,067,627'Schizophrenia associated genes, proteins and biallelic markers'20066,555,316'Schizophrenia associated gene, proteins and biallelic markers'20036,537,751'Biallelic markers for use in constructing a high density disequilibrium map of the human genome'20036,503,502'Nucleotide sequences, proteins, drugs and diagnostic agents of use in treating cancer'20036,476,208'Schizophrenia associated genes, proteins and biallelic markers'20026,346,381'Prostate cancer gene'20026,291,182'Methods, software and apparati for identifying genomic regions harboring a gene associated with a detectable trait'20016,265,546'Prostate cancer gene'20015,945,522'Prostate cancer gene'19995,541,060'Detection of glucokinase-linked early-onset non-insulin-dependent diabetes mellitus'19964,183,547'Wheelie skateboard'19804,095,817'Wheelie skateboard'1978Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2003Patents assigned to GENSET SA (7)· patent assignee history
2001–2007Based in Neuilly sur Seine, FR· patent location history
2008–2016Based in Le Mesnil le Roi, FR· patent location history
2012–2017Patents assigned to COHEN DANIEL (11)· patent assignee history
2013–2021Patents assigned to PHARNEXT (50)· patent assignee history
2013–2017Patents assigned to CHUMAKOV ILYA (9)· patent assignee history
2013–2017Patents assigned to NABIROCHKIN SERGUEI (8)· patent assignee history
2013–2020Based in Le Vesinet, FR· patent location history
2016–2021Based in Saint Cloud, FR· patent location history
2016–2019Based in New York, NY, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PHARNEXT | 50 | 2013–2021 |
| COHEN DANIELself | 11 | 2012–2017 |
| CHUMAKOV ILYA | 9 | 2013–2017 |
| NABIROCHKIN SERGUEI | 8 | 2013–2017 |
| GENSET SA | 7 | 1999–2003 |
Locations
| Location | Patents | Span |
|---|---|---|
| Saint Cloud, FR | 28 | 2016–2021 |
| Le Vesinet, FR | 17 | 2013–2020 |
| Le Mesnil le Roi, FR | 6 | 2008–2016 |
| Neuilly sur Seine, FR | 6 | 2001–2007 |
| New York, New York, US | 5 | 2016–2019 |